Skip to main content
. Author manuscript; available in PMC: 2021 May 28.
Published in final edited form as: J Med Chem. 2020 May 6;63(10):5501–5525. doi: 10.1021/acs.jmedchem.0c00442

Figure 9.

Figure 9.

Mini-Ames tests with liver S9 fraction activation (EBPI, Canada). Mutagen controls 2-aminoanthracene (2-AA) and HDAC inhibitor panobinostat (*p < 0.01 versus Ctrl) are Ames positive. 13a is not mutagenic as compared to panobinostat and the known mutagen 2-aminoanthracene.